MedPeer (6095.T) Stock Price
MedPeer Price
Over the last 15 years MedPeer grew revenue by 45.4% annually, reaching 14.95 B JPY. Earnings per share have grown at 37.4% per year over the last 12 years. For MedPeer, the net margin of 9.9% is down versus 13.7% a few years ago. At today's price the dividend yield works out to roughly 0.65%. The payout ratio is around 7% of earnings.
MedPeer stock price
MedPeer business model & stock analysis
Frequently asked questions about MedPeer
MedPeer Inc is primarily present in Japan. As a professional stock website, we provide comprehensive information about various stocks, including MedPeer Inc. MedPeer Inc is a leading medical networking platform operating primarily in Japan. With its innovative services, MedPeer Inc aims to enhance collaboration among medical professionals and promote knowledge sharing within the healthcare industry. Although MedPeer Inc's presence may expand in the future, currently, its primary focus is on the Japanese market. Stay updated on MedPeer Inc's latest developments and stock information with our website.
The business model of MedPeer Inc revolves around providing an online platform for healthcare professionals to collaborate and share medical knowledge. MedPeer offers a range of services including a peer-to-peer communication platform, medical case discussions, and professional networking opportunities. Through its digital platform, MedPeer aims to improve the quality of medical care by fostering knowledge exchange and promoting evidence-based practice among physicians. Additionally, MedPeer offers subscriptions for advanced features and personalized content to generate revenue. MedPeer Inc is dedicated to revolutionizing healthcare through digital innovation and enhancing the overall medical community's capabilities.
MedPeer Inc is primarily active in the healthcare industry. Their focus is on providing a platform for medical professionals to connect, share knowledge, and collaborate. MedPeer Inc offers a wide range of services and products that cater to the needs of healthcare professionals, including medical knowledge sharing, peer-to-peer consultations, and educational resources. With their expertise in the healthcare field, MedPeer Inc continues to revolutionize the way medical professionals communicate and contribute to the advancement of medical science and patient care.
The main competitors of MedPeer Inc in the market include firms like Doximity, Figure 1, and Doceree. These companies also operate in the medical networking and professional collaboration space, providing platforms for healthcare professionals to connect and exchange knowledge. However, MedPeer Inc distinguishes itself by focusing primarily on the Japanese healthcare industry and offering services catered specifically to the needs of medical professionals within this market. In recent years, MedPeer Inc has demonstrated strong growth and has become a leading player in the Japanese healthcare networking market.
MedPeer Inc is a Tokyo-based company established in 2004. It operates as a social networking platform exclusively for medical professionals. MedPeer Inc focuses on providing a secure online environment where doctors can connect, exchange knowledge, and collaborate. The company's platform enables doctors to consult and share medical experiences, contributing to the advancement of medical care and research. MedPeer Inc has gradually expanded its user base by offering various services, including medical case discussions, peer-reviewed journals, and conferences. With its commitment to enhancing communication and networking among doctors, MedPeer Inc has become a trusted platform in the medical industry.
MedPeer Inc, a prominent company in the healthcare industry, has achieved several significant milestones. Firstly, the company successfully launched its online platform, MedPeer, which connects medical professionals and facilitates knowledge sharing. This platform has gained immense popularity and is now widely used by doctors and healthcare practitioners. Additionally, MedPeer Inc has demonstrated strong financial growth, with increasing revenues and expanding user base. Furthermore, the company has made notable strategic partnerships with leading healthcare organizations, further solidifying its position in the market. MedPeer Inc continues to innovate and improve its services, making it a trusted and influential player in the healthcare industry.
MedPeer Inc, a leading healthcare technology company, represents values of innovation, collaboration, and quality in its corporate philosophy. With a strong commitment to improving medical practice, MedPeer provides an online platform that enables physicians to share knowledge and expertise, fostering professional growth and enhancing patient care. MedPeer Inc prioritizes creating a trusted community where healthcare professionals can learn from each other, discuss challenging cases, and stay updated with the latest medical advancements. Through its cutting-edge technology solutions and dedication to fostering a collaborative environment, MedPeer Inc continues to revolutionize the healthcare industry and contribute to the advancement of medical expertise.
7 analysts currently rate the MedPeer stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect MedPeer to generate revenue of 13.50 B JPY and earnings per share of 28.50 JPY.
Converted at the current exchange rate, the MedPeer share trades at 3.88 EUR (696.00 JPY).
The MedPeer share (6095.T) is listed on 2 stock exchanges, including: Tokio (JPX) (6095.T), Frankfurt (9UN.F).
MedPeer Inc is a leading Japanese company in the field of digital medical services and aims to revolutionize healthcare by incorporating the latest technologies and innovations into the medical sector. The company was founded in 2004 and is based in Tokyo, Japan. MedPeer's business model includes various divisions, including digital telemedicine, medical imaging, and medical education. MedPeer has developed a variety of innovative solutions that enable patients, doctors, and medical facilities to better communicate and exchange information. One of MedPeer's main products is a digital platform called "MedPeer," which allows doctors and medical professionals to discuss medical cases online and stay informed about the latest developments in medicine. The platform also offers an online shop where medical books and magazines can be purchased. Another important product from MedPeer is "MedPeer Telemedicine," a mobile app that allows patients to speak with doctors via video calls, receive a diagnosis, and obtain a prescription. The app also features a function for appointment scheduling and prescription renewal. The goal of MedPeer Telemedicine is to provide patients with access to medical care regardless of their location. MedPeer also offers medical imaging software solutions that enable doctors and medical facilities to securely store, share, and transmit medical images. The platform also allows doctors to view and edit medical images directly on mobile devices. Medical education is another important division of MedPeer. MedPeer offers online courses and training for doctors and medical professionals to expand their knowledge and skills and stay up to date. The company also provides support for medical exam preparations. In addition to its core products, MedPeer also offers a range of other digital medical services, such as the development of artificial intelligence (AI) algorithms to improve medical diagnostics and collaboration with other companies in the healthcare sector. Overall, MedPeer's business model is focused on improving healthcare through innovative technology and promoting better collaboration between patients, doctors, and medical facilities. MedPeer has already established a leading position in digital medicine in Japan and is expanding its activities internationally.
The expected revenue of MedPeer is 13.50 B JPY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of MedPeer is 618.71 M JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of MedPeer is currently 24.42. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MedPeer stock.
The price-to-sales ratio (P/S) of MedPeer is currently 1.12. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MedPeer stock.
The Eulerpool Quality Score for MedPeer is 5/10.
The ISIN of MedPeer is JP3921240002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of MedPeer is A1153F. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of MedPeer is 6095.T. The ticker symbol is used to trade MedPeer shares on the stock exchange.
Over the past 12 months, MedPeer paid a dividend of 4.50 JPY . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, MedPeer is expected to pay a dividend of 9.00 JPY.
The current dividend yield of MedPeer is 0.65 %.
MedPeer paid dividends every year for the past 3 years.
For the upcoming 12 months, dividends amounting to 9.00 JPY are expected. This corresponds to a dividend yield of 1.29 %.
MedPeer is assigned to the 'Health' sector.
To receive the latest dividend of MedPeer from 12/1/2025 amounting to 4.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/29/2025.
The last dividend was paid out on 12/1/2025.
In the year 2024, MedPeer distributed 4.5 JPY as dividends.
The dividends of MedPeer are distributed in JPY.
MedPeer stock
MedPeer Peer Group
MedPeer Ticker
MedPeer FIGI
All fundamentals and in-depth analysis of MedPeer
Our stock analysis for MedPeer stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedPeer. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.